Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta

agalsidase betaPositive

AI Analysis

Summary

Biosidus announced the operational start of its new bioreactor plant in Argentina, expanding manufacturing capacity and global supply capabilities for agalsidase beta biosimilar production.

Importance:3/10

Sentiment:

0.60

manufacturingcapacity_expansionbiosimilarsbioreactorsupply_chain

Related Companies

$GBCYD

Read the original article

Published by PR Newswire Pharma on August 26, 2026 9:00 PM

Read Original